HYSINGLA ER Trademark

Trademark Overview

On Friday, April 4, 2014, a trademark application was filed for HYSINGLA ER with the United States Patent and Trademark Office. The USPTO has given the HYSINGLA ER trademark a serial number of 86242700. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, August 6, 2025. This trademark is owned by Purdue Pharma L.P.. The HYSINGLA ER trademark is filed in the Pharmaceutical Products category with the following description:

Analgesics
hysingla er

General Information

Serial Number86242700
Word MarkHYSINGLA ER
Filing DateFriday, April 4, 2014
Status800 - REGISTERED AND RENEWED
Status DateWednesday, August 6, 2025
Registration Number4713945
Registration DateTuesday, March 31, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 5, 2014

Trademark Statements

Goods and ServicesAnalgesics
NOT AVAILABLE"ER"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 17, 2014
Primary Code005
First Use Anywhere DateMonday, January 5, 2015
First Use In Commerce DateMonday, January 5, 2015

Trademark Owner History

Party NamePurdue Pharma L.P.
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressStamford, CT 06901
Party NamePurdue Pharma L.P.
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressStamford, CT 06901
Party NamePurdue Pharma L.P.
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressStamford, CT 06901

Trademark Events

Event DateEvent Description
Thursday, April 17, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, June 29, 2014ASSIGNED TO EXAMINER
Monday, June 30, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 16, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 5, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 5, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 30, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 7, 2015TEAS STATEMENT OF USE RECEIVED
Wednesday, January 7, 2015USE AMENDMENT FILED
Wednesday, February 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 19, 2015STATEMENT OF USE PROCESSING COMPLETE
Friday, February 20, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 8, 2014NEW APPLICATION ENTERED
Saturday, February 21, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 31, 2015REGISTERED-PRINCIPAL REGISTER
Monday, May 15, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 15, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 28, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 9, 2021TEAS SECTION 8 & 15 RECEIVED
Thursday, June 17, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 17, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, June 17, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, March 31, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sunday, March 31, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, March 19, 2025TEAS SECTION 8 & 9 RECEIVED
Wednesday, August 6, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, August 6, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, August 6, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, August 6, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Related Keywords

hysingla analgesics